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ABSTRACT
Objectives: Portfolio theory has been suggested as a
means to improve the risk–return characteristics of invest-
ments in health-care programs through diversiﬁcation
when costs and effects are uncertain. This approach is
based on the assumption that the investment proportions
are not subject to uncertainty and that the budget can be
invested in toto in health-care programs.
Methods: In the present paper we develop an algorithm
that accounts for the fact that investment proportions in
health-care programs may be uncertain (due to the uncer-
tainty associated with costs) and limited (due to the size of
the programs). The initial budget allocation across pro-
grams may therefore be revised at the end of the invest-
ment period to cover the extra costs of some programs
with the leftover budget of other programs in the
portfolio.
Results: Once the total budget is equivalent to or exceeds
the expected costs of the programs in the portfolio, the
initial budget allocation policy does not impact the risk–
return characteristics of the combined portfolio, i.e., there
is no beneﬁt from diversiﬁcation anymore.
Conclusion: The applicability of portfolio methods to
improve the risk–return characteristics of investments in
health care is limited to situations where the available
budget is much smaller than the expected costs of the pro-
grams to be funded.
Keywords: cost-effectiveness analysis, diversiﬁcation,
portfolio theory, risk–return characteristics.
Introduction
The classical decision rule of cost-effectiveness anal-
ysis where programs are ranked according to the
expected cost-effectiveness ratio and successively
implemented, starting with the program with the
most favorable cost-effectiveness ratio (i.e., highest
expected return), until the budget is exhausted, rep-
resents a situation where the decision-maker is
assumed to be risk-neutral [1,2]. This is consistent
with Arrow and Lind’s argument that risk should be
irrelevant in public investment decisions because of
the ability to spread risk over many consumers [3].
However, risk-spreading may be limited in countries
where health insurance is provided in the private
market since the ﬁnancial burden to some individ-
uals may be substantial [4]. Moreover, even in coun-
tries where the ﬁnancial burden is spread across all
individuals such as in Switzerland where basic
health insurance is compulsory by law, the health
outcomes experienced by the individuals are not
transferable [5,6]. For example, patients with dia-
betic retinopathy cannot “share” with others their
loss of visual acuity. Others have argued that deci-
sion-makers may operate at a subsocietal level and
have to meet budgetary constraints and outcome
performance targets at the same time [2]. Therefore,
the probability of exceeding the budget and/or a
shortfall in health outcomes is of great importance
to many decision-makers. Hence, the uncertainty
associated with return on investment should be
accounted for when selecting health-care programs.
Much research interest has focused on methods
for handling uncertainty in cost-effectiveness anal-
ysis [7–13]. O’Brien and Sculpher have recently
started the discussion as to how portfolio theory
can be used to rank health-care programs with dif-
ferent risk–return parameters [2]. The decision-
maker’s preferences over expected return and risk,
and the principle of diversiﬁcation to reduce uncer-
tainty may be borrowed from portfolio theory and
applied in health-care ﬁnance [2]. However, these
concepts have so far been presented as a method to
deal with uncertainty in costs and effects without
explicit consideration of the size of the budget and
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the resource requirements of the programs in the
portfolio.
In health-care ﬁnance, the investment propor-
tions in the different programs may be limited by
the size of the programs. This is very different from
the situation in ﬁnancial economics where the
investment decision with regard to the mix of risky
assets is performed initially and the budget is usu-
ally spent in toto. Moreover, in health-care ﬁnance,
the investment proportions are usually uncertain
due to the uncertainty associated with the costs of
the programs, as opposed to being certain in ﬁnan-
cial economics. Health-care programs may happen
to need more or less resources than initially budg-
eted. In such a situation the decision-maker may
want to use the remainder of the budget of some
programs to cover the additional expenses of other
programs at the end of the year. The applicability of
portfolio methods in health-care therefore needs to
be recast in that light.
This paper demonstrates the limitations of the
applicability of portfolio theory in health-care
ﬁnance that may result as a consequence of these
distinct characteristics. In the next section we brieﬂy
review traditional portfolio theory. We then suggest
an algorithm that accounts for the fact that deci-
sion-makers may eventually want to reallocate the
budget between programs at the end of the year. We
then demonstrate our concept using a hypothetical
example and conclude by discussion of our
approach.
Portfolio Theory Reviewed
The principle of diversiﬁcation can best be
described using a portfolio of two risky assets [14].
These are easy to analyze and demonstrate the prin-
ciples and considerations that apply to portfolios of
many assets. Instead of analyzing the risk and
return parameters of bonds and stocks, we consider
health-care programs as risky assets. Return on
investment in ﬁnancial economics is usually
expressed in percentages. To be in line with this con-
vention, we deﬁne return on investment in a health-
care program r as
(1)
where C is the cost of the program, E the health
beneﬁt of the program (e.g., expressed as QALYs),
and l the decision-maker’s willingness to pay for a
QALY. The numerator of the equation above is
equivalent to the net monetary beneﬁt (NMB)






a linear transformation of the effectiveness–cost
ratio as deﬁned by O’Brien and Sculpher [2]:
(2)
with the difference that we used absolute costs and
effects rather than incremental costs and effects.
However, Since E and C are stochastic variables, we
do not elaborate on algebraic methods to estimate
conﬁdence intervals for our measure of return as the
same well-known difﬁculties associated with ratio
statistics would be encountered that led to a bewil-
dering number of methods for estimating a conﬁ-
dence interval for the cost-effectiveness ratio [8]. In
this paper, we will rather rely on computer-intensive
resampling methods to assess the variability in
return.
Now, let us consider two health-care programs A
and B. Program A offers an expected return rA of
10% with a standard deviation sA of 3%, and pro-
gram B offers an expected return rB of 15% with a
standard deviation sB of 5%. Denote the proportion
invested in program A by wA and the remainder, 1-
wA, invested in program B by wB. The rate of return
of the combined portfolio rP is
rP = wArA  + wBrB (3)
The expected rate of return of the two-program
portfolio is deﬁned as
E(rP) = wAE(rA) + wBE(rB) (4)
and the variance of the portfolio comprising the two
health-care programs is deﬁned as
sP2 = wA2sA2 + wB2sB2 + 2wAwBrABsAsB (5)
We can see from Equation 5 that the standard devi-
ation of the combined portfolio, given the standard
deviation of the individual programs, increases
when the correlation coefﬁcient rAB is higher. The
smaller rAB, the more effective the reduction in total
risk will be.
A portfolio opportunity set shows all risk–return
combinations that can be constructed by varying
the investment proportions. Figure 1 shows such a
portfolio opportunity set assuming that the correla-
tion between the return of program A and B as spec-
iﬁed above is -0.5. The section of the curve that lies
above the minimum variance portfolio (indicated by
the intersection of the horizontal broken line with
the portfolio opportunity set) is called the efﬁcient
frontier. An investor typically chooses a portfolio
that lies on the efﬁcient frontier since for every com-
bination of wB and wA that lies below the minimum
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and wA above the minimum variance portfolio that
offers more returns for the same degree of risk. The
investor has then to decide on the proportions to
invest in program A and B. This is accomplished by
superimposing the investor’s indifference map (i.e.,
a set of indifference curves) on the efﬁcient frontier.
An indifference curve connects all points on the
risk–return plane that offer the same level of utility
to a decision-maker. Since we assume that decision-
makers prefer more expected return and less risk,
indifference curves that lie in the northwest of the
indifference map indicate a higher level of utility.
The indifference curve that is tangent to the efﬁcient
frontier therefore reﬂects the combination of wB and
wA with the highest utility. Such a curve is shown for
three different investors in Figure 1. The slope of
the indifference curve measures the rate at which a
decision-maker is willing to engage in a riskier
investment (indicated on the horizontal axis) in
return for an increase in expected return (indicated
on the vertical axis), while holding utility constant.
The steeper the slope of the indifference curve is the
more expected return is needed to compensate for
an increase in an additional unit of risk. The slope
of the indifference curve depends on the decision-
maker’s risk-tolerance. An investor with indiffer-
ence curve U2 would choose portfolio R. A more
risk-averse investor with a steeper indifference
curve U1 would choose portfolio Q. And a risk-
seeking investor with indifference curve U3 would
choose portfolio S. The indifference map of a deci-
sion-maker is difﬁcult to construct in practice.
However, different methods are available to elicit
the decision-maker’s risk-posture, which are
described in detail elsewhere (e.g., [14]).
Stochastic Costs and Budget Allocation
We have so far simply adopted the portfolio meth-
ods in health-care ﬁnance. However, there are some
important differences to note between budget allo-
cation in health-care ﬁnance and budget allocation
in ﬁnancial economics. In ﬁnancial economics, the
proportion of the budget used by the different risky
assets is not uncertain. Let us say we want to invest
50% of our budget in Microsoft stocks and 50% in
Intel stocks. In ﬁnancial economics, we can com-
pletely spend our budget as contemplated. We can
do so because our budget is usually much smaller
than the value of all available shares of a stock on
the market [14]. This is different from the situation
in health-care ﬁnance where resource use is uncer-
tain and the investment proportions limited by the
size of the programs. Note that the uncertainty of
return on investment in ﬁnancial economics stems
from the variability of the market value of risky
assets. In health-care ﬁnance, on the other hand, the
uncertainty of return on investment results from the
variability associated with both resource use and
health outcomes. Because resource use is uncertain,
the proportion of the budget used by health-care
programs is also uncertain. Hence, we do not know
beforehand whether our budget will be completely
consumed or whether a part of the budget will be
left at the end of the year. This has important impli-
cations for the applicability of portfolio theory in
health-care ﬁnance and the principle of diversiﬁca-
tion is not applicable without modiﬁcation. We
therefore need an algorithm to handle this distinct
characteristic in health-care ﬁnance.
When resource use is uncertain, the proportion
of the budget initially allocated to a program does
not necessarily correspond to the proportion of the
budget that is actually consumed by that program.
This usually occurs when a program turns out to
use fewer resources than budgeted. If there are other
programs in the portfolio that turn out to need a
larger proportion of the budget at the end of the
year, it makes sense to shift the remaining budget of
the ﬁrst program to these latter programs to cover
the extra costs. If there is still some leftover after
this reallocation, then that unused part of the
budget may be seen as an investment in a risk-free
asset, e.g., money market instruments. We can for-
mulate this budget allocation policy more formally
Figure 1 The optimal risky portfolio for three decision-makers with
different risk postures. E(rP) denotes portfolio expected return, sP
denotes portfolio standard deviation. Utility increases with more
return and less risk. R is the optimal risky portfolio for a decision-
maker with indifference curve U2; Q is the optimal risky portfolio for
a more risk-averse decision maker with indifference curve U1; S is the
optimal risky portfolio for a risk-seeking decision maker with indiffer-
ence curve U3.


















for a situation in which we have a portfolio of two
health-care programs. As already mentioned in the
previous section, a portfolio of two health-care pro-
grams is straightforward to analyze and the same
concepts and principles also apply to portfolios
comprising multiple programs.
We deﬁne the rate of return of the combined
portfolio rP as:
We have distinguished four situations that might
occur in a two-program portfolio when resource use
is uncertain:
1. The costs of both program A (CA) and B (CB)
exceed the budget initially allocated to these
programs (BA denotes the budget for program A
and BB denotes the budget for program B). In
this case we calculate portfolio return as
described in Equation 3 where BA/BT and BB/BT
represent the respective investment proportions
(BT denotes the total budget), i.e., BA/BT corre-
sponds to wA and BB/BT to wB in Equation 3.
2. The costs of both program A (CA) and B (CB) are
lower than the budget initially allocated to these
programs. In this case there is some budget left
at the end of the year. This leftover budget can
be seen as an investment in a risk-free asset,
which yields a certain rate of return rC. Portfolio
return is then calculated by multiplying the
three investment proportions with the respec-
tive rate of return. The investment proportions
are CA/BT for program A and CB/BT for program
B. The investment proportion for the risk-free
asset is the remainder (BT – CA – CB)/BT.
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3. The costs of program A (CA) are lower than the
budget initially allocated to this program, but
the costs of program B (CB) exceed the budget.
In this case we reallocate the budget not used by
program A to program B at the end of the year.
The investment proportions of program A and
B are then CA/BT and (BB + BA – CA)/BT, respec-
tively. However, there is the possibility that the
budget not used by program A exceeds the
resource requirements of program B. In that
case the investment proportions are CA/BT for
program A, CB/BT for program B, and (BT –
CA – CB)/BT for the risk-free asset.
4. The costs of program B (CB) are lower than the
budget initially allocated to this program, but
the costs of program A (CA) exceed the budget.
In this case we reallocate the budget not used by
program B to program A at the end of the year.
The investment proportions of program B and
A are then CB/BT and (BA + BB – CB)/BT, respec-
tively. However, there is the possibility that the
budget not used by program B exceeds the
resource requirements of program A. In that
case the investment proportions are CA/BT for
program A, CB/BT for program B, and (BT –
CA – CB)/BT for the risk-free asset.
Note that the costs of program A and B are
uncertain. This renders those investment propor-
tions, which include CA and CB in their deriva-
tion, also uncertain. Only in those instances where
CA > BA and CB > BB is true with certainty, the
investment proportions are certain, because BA/BT
and BB/BT are not subject to a distribution (i.e.,
BA, BB and BT are not random variables). There-
fore, portfolio theory as described previously can
only be applied in health-care ﬁnance when the
initial investment proportions are certain, which
occurs when P(CA > BA, CB > BB) is one or close to
one.
Note that our approach implies that the budget is
allocated across programs at the beginning of the
year before future costs and effects are observed.
However, we specify in advance at the beginning of
the year how we would handle any remaining
budget if it was not completely used up by the
respective program, e.g., to cover eventual extra
costs that accrued to other programs in the portfo-
lio. Whether the respective programs actually will
or will not exceed the budget is of course not known
a priori and therefore uncertain. Our algorithm
therefore represents a dynamic budget allocation
policy in the presence of uncertainty about the
future state of the world. In the following section
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we will demonstrate our algorithm using a hypo-
thetical example.
A Hypothetical Example
Consider the two health-care programs shown in
Table 1. Mean costs and effects and standard devi-
ation of costs and effects are shown. Let the corre-
lation between costs and effects be 0.6 for program
A and 0.7 for program B. Moreover, the effects of
the two health-care programs are negatively corre-
lated with a coefﬁcient of -0.5. Note that any cor-
relation between the rate of return of health-care
programs results from the correlation of costs and
effects between and within the programs under con-
sideration. Hence, it is more appropriate to model
this latter correlation matrix than the resulting cor-
relation between the rates of returns. In Table 2 we
also show the NMB and the return statistics of pro-
gram A and B.
We can calculate the return on investment and
standard deviation for a given budget level and dif-
ferent initial investment proportions using simula-
tion and the algorithm described in the previous
section as follows:
(a) take a sample of costs (CA and CB) and effects
(EA and EB) from the respective distributions
and calculate portfolio return (rP) using the
algorithm described above;
(b) repeat the previous step a large number of
times;
(c) compute the mean and standard deviation of
the resulting distribution of portfolio return;
(d) repeat steps (a)–(c) for each budget level and
initial budget allocation policy.
We performed this simulation exercise using a
value of $100,000 per QALY for the ceiling ratio.
Moreover, we used a ﬁxed value of 5% for rC, i.e.,
the return of the risk-free asset.
The results of our simulation exercise are shown
in  Figs. 2  and  3.  The  analysis  was  conducted  for
the budget levels $10,000,000, $20,000,000, and
$30,000,000. As we can see in Figure 2A, at the
budget level of $10,000,000, expected portfolio
return decreases as a larger proportion of the
budget is allocated to program A. Moreover, at the
same budget level, portfolio standard deviation
decreases with increasing diversiﬁcation of the
budget between program A and B, and increases
again as the portfolio becomes less diversiﬁed
(Fig. 2B). Plotting portfolio expected return against
portfolio standard deviation for all investment pro-
Table 1 Mean costs and standard deviation (mC, sC) and
mean effects and standard deviation (mE, sE) for two health-
care programs
Program mC sC mE sE r*
A 10,000,000 500,000 115 10 0.6
B 20,000,000 2,000,000 250 10 0.7
*The correlation of  costs and effects per treatment alternative is denoted by r.
Effects of  the two programs are also correlated with r = -0.5.
Table 2 Expected net monetary beneﬁt E(NMB) and stand-
ard deviation and expected return E(r) and standard deviation
for two health-care programs
Program E(NMB)* sNMB E(r) sr
A 1,500,166 807,106 14.99% 8.03%
B 4,999,906 1,488,631 25.93% 10.06%
*Assuming l = $100,000/QALY.
The values in this table were estimated using simulation (10,000 iterations) and
truncated normal distributions (costs and effects truncated at zero) from
Table 1.
Figure 2 A. Portfolio expected return as a function of  initial budget
allocation. B. Portfolio standard deviation as a function of  initial budget
allocation. BA denotes the budget allocated to program A; BB denotes
the budget allocated to program B; BT denotes the total budget; E(rP)
denotes portfolio expected return in percentage; and sP denotes port-
folio standard deviation in percentage.
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portions allows us to construct the portfolio oppor-
tunity set as shown in Figure 3.
As we can see in Figure 2A, at the budget level
$20,000,000, expected portfolio return decreases as
a larger proportion of the budget is initially allo-
cated to program A. However, when the budget ini-
tially allocated to program A exceeds $10,000,000
(i.e., mean costs of program A), there is no change
in the risk–return characteristics of the portfolio
(Fig. 2A and B). Program A consumes on average
$10,000,000 and the remainder will be reallocated
to program B. Increasing the initial proportion allo-
cated to program A has no effect because this does
not impact the actual resource requirements of pro-
gram A (Fig. 2A and B). For example, the policy of
initially allocating $12,000,000 to program A and
8,000,000 to program B  offers  the  same  risk–
return  characteristics  as allocating $18,000,000 to
program A and $2,000,000 to program B. The pos-
sible risk–return combinations of the combined
portfolio at the budget level $20,000,000 are shown
in Figure 3.
If we further increase the total budget to
$30,000,000, which corresponds to the total
expected costs of program A and B, we see that the
risk–return characteristics are identical for all initial
budget allocation policies (Fig. 2A and B). That is,
the portfolio opportunity set collapses to a single
point on the risk–return plane (Fig. 3). Varying the
investment proportions has no effect on the risk–
return characteristics of the combined portfolio.
This is because, no matter how the budget is ini-
tially allocated, our algorithm ensures that program
A receives on average $10,000,000 and program B
$20,000,000, which corresponds to their average
resource requirements.
Discussion
The use of portfolio theory in health-care ﬁnance
has been discussed by a number of authors [2,17].
However, the applicability of the tools of portfolio
analysis in health care, in particular the principle of
diversiﬁcation, may be limited due to the limited
size of health-care programs and the uncertainty
associated with resource requirements. The most
important difference between budget allocation in
health-care ﬁnance and budget allocation in ﬁnan-
cial economics is that the investment proportions in
health-care ﬁnance are usually uncertain and lim-
ited, as opposed to certain and usually unlimited in
ﬁnancial economics. Because resource use of health-
care programs is uncertain, the investment propor-
tions are also uncertain. Programs may therefore
happen to need more or less resources than initially
budgeted. In such a situation the decision-maker
may want to use the remainder of the budget of
some programs to cover the additional expenses of
other programs at the end of the year. Our algo-
rithm ensures that resources not used by the respec-
tive programs are reallocated to those programs in
need of more resources.
An important result of this budget allocation pol-
icy is that it does not matter how the budget is ini-
tially divided up between the programs when the
total budget is as large as the expected costs of all
the programs in the portfolio. The question of
whether the principle of diversiﬁcation is relevant in
health-care ﬁnance then arises. It may be argued
that one usually wishes to budget health-care pro-
grams so that the whole program can be ﬁnanced.
However, when the budget corresponds to the
expected costs of the portfolio, there is a 50%
chance that we will need more resources, which
might already be seen as an unacceptable ﬁgure in
practice. But note that there is already no beneﬁt
from diversiﬁcation anymore at this budget level.
The implication for decision-makers is that the ini-
tial budget allocation and hence the principle of
diversiﬁcation does not matter in these situations.
The applicability of portfolio theory in health
care may prove difﬁcult because of other limitations
as well. Information on the correlation of costs and
effects between an intervention and up-stream or
down-stream interventions are usually not available
from randomized controlled trials as these mostly
only focus on the intervention of interest. In addi-
tion, portfolio theory assumes that programs can be
implemented partially (i.e., assumes complete divis-
ibility), and that the return on investment is inde-
pendent of the size of the program (i.e., assumes
Figure 3 Portfolio opportunity set for three different budget levels.
E(rP) denotes portfolio expected return in percentage, sP denotes
portfolio standard deviation in percentage.















Portfolio Theory and Cost-Effectiveness Analysis 601
constant returns to scale). Partial implementation
would imply that, for example, half of the HIV-
infected population would be treated with new
medications whereas the other half would get the
less effective cheaper therapy. Such a policy is cer-
tainly problematic because of ethical reasons [18].
Constant return to scales would imply that, for
example, buying radiation equipment to treat can-
cer patients would be equally cost-effective when
only 10 cancer patients are treated per year com-
pared to 1000 patients. However, in the case of
large capital costs, health-care programs usually
exhibit an increasing return to scale [19]. The lim-
itations of the assumptions of complete divisibility
and constant returns to scale are further described
in detail elsewhere [12,13,19–21].
In conclusion, the applicability of portfolio meth-
ods to improve the risk–return characteristics of
investments in health care is limited to situations
where  the  available  budget  is  much  smaller  than
the expected costs of the programs to be funded.
The advantage of diversiﬁcation disappears once the
total budget corresponds to or exceeds the expected
costs of the programs in the portfolio. The develop-
ment of methods that address the limitations of tra-
ditional portfolio analysis in health care should be a
research priority.
Dr Sendi was supported by the Swiss National Science
Foundation (grant # 823B-056512) and the Lichtenstein-
Stiftung.
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